US Broker Ratings

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a 72% Potential Upside in the Biotech Sector

Immunocore Holdings plc (NASDAQ: IMCR), a pioneering biotechnology company based in the United Kingdom, is capturing attention with its promising portfolio of immunotherapies targeting cancer, infectious..

Viking Therapeutics, Inc. (VKTX): Investor Outlook with a Potential 227% Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has been capturing the attention of investors with its compelling pipeline of novel therapies aimed at treating..

Innoviva, Inc. (INVA) Stock Analysis: Uncovering a 154.87% Potential Upside in the Biotechnology Arena

Innoviva, Inc. (NASDAQ: INVA) stands out as a noteworthy player in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.35 billion,..

Belite Bio, Inc (BLTE) Investor Outlook: Exploring the 38% Potential Upside in Biotechnology

Belite Bio, Inc (BLTE) stands out in the competitive biotechnology sector with its innovative approach to tackling unmet medical needs in retinal degenerative diseases. With a..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Complex Terrain of Early Cancer Detection with a Market Cap of $1.44 Billion

GRAIL, Inc. (NASDAQ: GRAL) is making waves in the healthcare industry with its innovative approach to cancer diagnostics. Specializing in multi-cancer early detection testing, GRAIL is..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 54.50% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a significant player in the healthcare sector, specifically within the health information services industry. With its innovative platform offering..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 211.57% Potential Upside in Biotech

Dyne Therapeutics, Inc. (NASDAQ: DYN) is currently a standout in the biotechnology sector, captivating investor interest with a remarkable potential upside of 211.57%. Headquartered in Waltham,..

ANI Pharmaceuticals, Inc. (ANIP): Growth Potential and a 28.47% Upside Ignite Investor Interest

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is capturing the attention of investors with its promising outlook in the healthcare sector, particularly within the specialty and generic drug..

Warby Parker Inc. (WRBY) Stock Analysis: Strong Buy Ratings Amidst a Challenging Valuation Landscape

Warby Parker Inc. (NYSE: WRBY), a key player in the Healthcare sector’s Medical Instruments & Supplies industry, continues to capture investor attention with its innovative approach..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a Potential 30% Upside in the Medical Device Sector

UFP Technologies, Inc. (NASDAQ: UFPT), a key player in the healthcare sector, particularly within the medical device industry, presents an intriguing opportunity for investors seeking growth..

AdaptHealth Corp. (AHCO) Stock Analysis: Unveiling a 45.98% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, operates within the medical devices industry, providing essential home medical equipment and services across the..

Adaptive Biotechnologies Corpor (ADPT) Stock Analysis: Insights into its 25.2% Revenue Growth and Investor Ratings

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is garnering attention in the biotech sector, particularly due to its impressive 25.2% revenue growth and a strong consensus from analysts...

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Investors Eye a 54% Potential Upside

For investors seeking opportunities in the healthcare sector, Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) presents a compelling case for consideration. As a global biopharmaceutical company, Amneal specializes..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring an 86.95% Potential Upside Amidst Biotech Volatility

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent name in the biotechnology sector, has captured investor attention with its high potential upside of 86.95%, as indicated by..

Arcellx, Inc. (ACLX) Stock Analysis: A Biotech with 66% Upside Potential

Arcellx, Inc. (NASDAQ: ACLX), a promising player in the biotechnology sector, is capturing the attention of growth-oriented investors due to its potential upside of 66.34%. With..

Ardent Health, Inc. (ARDT) Stock Analysis: Strong Buy Ratings and 48.52% Upside Potential

Ardent Health, Inc. (NASDAQ: ARDT) is catching the attention of investors, boasting a robust 48.52% potential upside, as it currently trades at $13.68. Situated in the..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: Strong Buy Ratings Signal Potential 22% Upside

For investors eyeing the healthcare sector, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a unique opportunity within the medical devices industry. Based in San Jose, California, PROCEPT..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a Potential 272% Upside in the Biotech Sector

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to tackling chronic diseases. Based in..

Omnicell, Inc. (OMCL) Stock Analysis: A 25% Potential Upside Awaits Patient Investors

Omnicell, Inc. (NASDAQ: OMCL), a key player in the healthcare sector, operates within the health information services industry, providing innovative medication management solutions to healthcare systems..

CG Oncology, Inc. (CGON) Stock Analysis: Exploring a 121.81% Potential Upside in Biotech

Investors with a keen eye on the biotechnology sector might find CG Oncology, Inc. (NASDAQ: CGON) an intriguing opportunity, given its significant potential upside of 121.81%...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds